인쇄하기
취소
|
Since Donald Trump is elected as the president of the United States, the Korean pharmaceutical industry is also expected to encounter huge impacts.
While negative anticipations, such as renegotiation of the Korea-US FTA, have been made, repeal of Obama Care might energize exports of Korean generics.
Moreover, because there is a high chance of fluctuation in exchange rate due to the election...